220 related articles for article (PubMed ID: 32449208)
1. Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors.
Abu Rmilah AA; Lin G; Begna KH; Friedman PA; Herrmann J
Int J Cancer; 2020 Dec; 147(11):3160-3167. PubMed ID: 32449208
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.
Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664
[TBL] [Abstract][Full Text] [Related]
3. Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors.
Kloth JS; Pagani A; Verboom MC; Malovini A; Napolitano C; Kruit WH; Sleijfer S; Steeghs N; Zambelli A; Mathijssen RH
Br J Cancer; 2015 Mar; 112(6):1011-6. PubMed ID: 25742483
[TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
5. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
Ryan K; Benz P; Zosel A; Farkas A; Theobald J
Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
[TBL] [Abstract][Full Text] [Related]
6. QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Ghatalia P; Je Y; Kaymakcalan MD; Sonpavde G; Choueiri TK
Br J Cancer; 2015 Jan; 112(2):296-305. PubMed ID: 25349964
[TBL] [Abstract][Full Text] [Related]
7. Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.
Vieweg WV; Hasnain M; Hancox JC; Baranchuk A; Digby GC; Kogut C; Crouse EL; Koneru JN; Deshmukh A; Pandurangi AK
Psychopharmacology (Berl); 2013 Aug; 228(4):515-24. PubMed ID: 23812796
[TBL] [Abstract][Full Text] [Related]
8. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
10. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
11. QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.
Berger FA; Monadian N; de Groot NMS; Santbergen B; van der Sijs H; Becker ML; Broers AEC; van Gelder T; van den Bemt PMLA
Br J Clin Pharmacol; 2018 Feb; 84(2):369-378. PubMed ID: 29057492
[TBL] [Abstract][Full Text] [Related]
12. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
13. Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs.
Diemberger I; Massaro G; Cubelli M; Rubino D; Quercia S; Martignani C; Ziacchi M; Biffi M; Bernardi A; Cacciari N; Zamagni C; Boriani G
Eur J Clin Pharmacol; 2015 Aug; 71(8):1001-9. PubMed ID: 26028320
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib Increases the Incidence of QT Prolongation in Patients with Non-Small Cell Lung Cancer.
Maimaitituersun G; Abulimiti B; Jin M; Dong X; Fu Z
Int Heart J; 2023; 64(3):365-373. PubMed ID: 37258113
[TBL] [Abstract][Full Text] [Related]
15. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain.
Madden K; Jo E; Williams JL; Liu D; Bruera E
J Pain Symptom Manage; 2019 Oct; 58(4):678-684. PubMed ID: 31195079
[TBL] [Abstract][Full Text] [Related]
16. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
[TBL] [Abstract][Full Text] [Related]
17. Consistency of heart rate-QTc prolongation consistency and sudden cardiac death: The Rotterdam Study.
Niemeijer MN; van den Berg ME; Deckers JW; Franco OH; Hofman A; Kors JA; Stricker BH; Rijnbeek PR; Eijgelsheim M
Heart Rhythm; 2015 Oct; 12(10):2078-85. PubMed ID: 26165945
[TBL] [Abstract][Full Text] [Related]
18. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
Vrtovec B; Knezevic I; Poglajen G; Sebestjen M; Okrajsek R; Haddad F
Am J Cardiol; 2013 Mar; 111(6):886-90. PubMed ID: 23273526
[TBL] [Abstract][Full Text] [Related]
19. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.
Hasnain M; Vieweg WV
CNS Drugs; 2014 Oct; 28(10):887-920. PubMed ID: 25168784
[TBL] [Abstract][Full Text] [Related]
20. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.
Reddy S; Hui D; El Osta B; de la Cruz M; Walker P; Palmer JL; Bruera E
J Palliat Med; 2010 Jan; 13(1):33-8. PubMed ID: 19824814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
